Back to Search
Start Over
Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer.
- Source :
-
Annals of translational medicine [Ann Transl Med] 2019 Mar; Vol. 7 (Suppl 1), pp. S42. - Publication Year :
- 2019
-
Abstract
- Competing Interests: Conflicts of Interest: Dr. PN Aguiar Jr reports speaker fees from MERCK CO, outside the submitted work. Prof. De Mello reports consultant/advisory board for Pfizer, Zodiac, MSD; Speaker Honoraria from Astrazenenca, Novartis, Educational Grants: Roche, Merck-Group; Travel Grant: BMS; Expert honoraria from National Science Center, Poland. The other authors have no conflicts of interest to declare.
Details
- Language :
- English
- ISSN :
- 2305-5839
- Volume :
- 7
- Issue :
- Suppl 1
- Database :
- MEDLINE
- Journal :
- Annals of translational medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31032321
- Full Text :
- https://doi.org/10.21037/atm.2019.02.27